相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes
Nicolas Margot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients
Anne-Genevieve Marcelin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Clinical targeting of HIV capsid protein with a long-acting small molecule
John O. Link et al.
NATURE (2020)
Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults
Joel E. Gallant et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Joel Gallant et al.
LANCET (2017)
Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1-Infected Patients: Week 48 Results
Joel E. Gallant et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4
Nicolas A. Margot et al.
ANTIVIRAL RESEARCH (2012)
Phenotypic Susceptibility to Bevirimat in Isolates from HIV-1-Infected Patients without Prior Exposure to Bevirimat
Nicolas A. Margot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
CJ Petropoulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
